Home
Conditions
Noonan Syndrome

Clinical trial condition

Noonan Syndrome

Explore clinical trials studying Noonan Syndrome. Study availability and eligibility vary by location and protocol.

38 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

Noonan Syndrome trial results

Recruiting

GROWing Up With Rare GENEtic Syndromes

NCT04463316

Conditions: 17p- Deletiesyndrome, 1q25-32 Deletie, 22q11 Deletion Syndrome, +138 more
Locations: Erasmus Medical Center Rotterdam, South Holland, Netherlands

View Trial Details

Not yet recruiting

Clinical Trial of a MEK Inhibitor for RASopathy-Associated Severe Infantile Hypertrophic Cardiomyopathy: Baby MERIT

NCT07817186

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

Link Between Abnormal Bleeding and Coagulation Disorders in Noonan Syndromes

NCT07259135

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +12 more
Locations: CHU de Bordeaux, Service Hématologie Biologique Bordeaux, France

View Trial Details

Enrolling by invitation

Palliative Care Needs of Children With Rare Diseases and Their Families

NCT06938542

Conditions: Abnormalities, Multiple, Anxiety Disorders, Arthrogryposis Congenita Multiplex With Intestinal Atresia, +84 more
Locations: Children's National Hospital Washington D.C., District of Columbia, United States

View Trial Details

Enrolling by invitation

French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome

NCT05308927

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +9 more
Locations: Centre Hospitalier Universitaire D'Angers-2 Angers, France

Ap-Hp-Hopital de Bicetre-2 Le Kremlin-Bicêtre, France

Hopital Des Enfants-2 Toulouse, France

View Trial Details

Active, not recruiting

A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment

NCT06668805

Conditions: Bone Diseases, Bone Diseases, Developmental, Cardiovascular Abnormalities, +14 more
Locations: Childrens Hospital Los Angeles Los Angeles, California, United States

Children's Hospital of Orange County Main Campus - Orange Orange, California, United States

Children's Hospital Colorado Aurora, Colorado, United States

Nemours Children's Hospital, Delaware (Alfred I. Dupont Hospital for Children) Wilmington, Delaware, United States

View all 38 locations

View Trial Details

Active, not recruiting

A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9

NCT05723835

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Chromosome Disorders, +25 more
Locations: Univ of AL at Birmingham_BRM Birmingham, Alabama, United States

Sutter Valley Med Fdt Ped Endo Sacramento, California, United States

Rocky Mt Ped and Endo Centennial, Colorado, United States

Childrens National Medical Ctr Washington D.C., District of Columbia, United States

View all 18 locations

View Trial Details

Active, not recruiting

A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow

NCT05330325

Conditions: Cardiovascular Abnormalities, Cardiovascular Diseases, Chromosome Disorders, +24 more
Locations: Univ of AL at Birmingham_BRM Birmingham, Alabama, United States

Children's Hospital Los Angeles - Endocrinology Los Angeles, California, United States

Sutter Valley Med Fdt Ped Endo Sacramento, California, United States

Rady Childrens Hosp San Diego San Diego, California, United States

View all 199 locations

View Trial Details

Active, not recruiting

Vosoritide for Selected Genetic Causes of Short Stature

NCT04219007

Conditions: Bone Diseases, Bone Diseases, Developmental, Cardiovascular Abnormalities, +16 more
Locations: Children's National Hospital Washington D.C., District of Columbia, United States

View Trial Details

Completed

A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors

NCT04670679

Conditions: Advanced or Metastatic Solid Tumors, Carcinoma, Carcinoma, Squamous Cell, +33 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Sarah Cannon Research Institute (Florida Cancer Specialists) Sarasota, Florida, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Washington University St Louis, Missouri, United States

View all 14 locations

View Trial Details

Noonan Syndrome

Noonan Syndrome trial results

Related conditions